ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 53 filers reported holding ENZON PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | – | 60 | -89.3% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 560 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | 0.0% | 560 | 0.0% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 560 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $1,000 | – | 560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBERT MANAGEMENT CORP | 351,700 | $703,000 | 0.42% |
| Baupost Group | 7,691,453 | $15,383,000 | 0.38% |
| PRICE MICHAEL F | 748,200 | $1,496,000 | 0.20% |
| Rotella Capital Management, Inc. | 25,542 | $51,000 | 0.16% |
| Gruss Capital Management LP | 517,000 | $1,034,000 | 0.11% |
| ALGERT GLOBAL LLC | 124,891 | $250,000 | 0.08% |
| Spark Investment Management LLC | 139,800 | $267,000 | 0.07% |
| Icahn Capital | 5,904,863 | $11,810,000 | 0.06% |
| NWAM LLC | 49,326 | $99,000 | 0.05% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 131,389 | $262,000 | 0.03% |